Parathyroidectomy is a surgical procedure used to treat hypercalcemia caused by primary hyperparathyroidism. This operation primarily targets lesions such as parathyroid adenomas, hyperplasia, or carcinomas, by removing part or all of the abnormal parathyroid tissue to reduce excessive secretion of parathyroid hormone (PTH) and restore blood calcium levels to normal ranges. The goal of the surgery is to resolve bone lesions, renal damage, and neuro-muscular symptoms caused by hypercalcemia, while reducing the risk of long-term complications.
This treatment is commonly indicated for patients with poor response to medication or with evident organ damage. The surgical approach depends on the location and severity of the lesions. Postoperative monitoring of blood calcium and PTH levels is essential to ensure treatment efficacy. The procedure has a clear anatomical basis but must be performed by experienced surgeons to minimize complications.
Parathyroidectomy is mainly divided into total removal (excision of all four glands), subtotal removal (preserving some normal glands), and partial removal (only removing diseased glands). The choice depends on the extent of the lesions; for example, solitary adenomas are usually treated with partial removal. The mechanism involves removing the hyperfunctioning parathyroid tissue to lower blood calcium levels and restore metabolic balance.
The surgery typically combines imaging-guided techniques (such as ultrasound or nuclear medicine imaging) to locate the abnormal glands, and may use nerve monitoring systems to protect the recurrent laryngeal nerve. After removal, residual glands or transplanted tissue can maintain basic PTH secretion, preventing permanent hypoparathyroidism. The procedure is performed under general anesthesia, with incisions usually placed in the neck skin fold to minimize scarring.
The primary indication is for primary hyperparathyroidism, especially symptomatic hypercalcemia (serum calcium >10.5 mg/dL) or asymptomatic patients with persistent calcium abnormalities. Other indications include recurrence after surgery, suspected malignancy, or cases where medication (such as bisphosphonates) cannot control the condition. Patients with chronic renal failure who develop renal hyperparathyroidism may also benefit from surgery to improve calcium-phosphate metabolism disorders.
In special cases, such as familial hyperparathyroidism or diseases related to genetic mutations, surgery can be a definitive cure. However, other causes of secondary hypercalcemia (such as vitamin D intoxication) must be excluded, and the lesions confirmed to be located in the parathyroid glands.
This is an invasive surgical procedure performed under general anesthesia in the operating room. The process includes a neck incision, localization of the parathyroid glands, removal of diseased tissue, and intraoperative frozen section pathology to confirm the extent of the lesion. The operation lasts approximately 1-3 hours, with hospitalization typically lasting 1-3 days, but full recovery may take 2-4 weeks.
There is no concept of "dosage," but the extent of the surgery should be adjusted according to the severity of the lesions. For example, a solitary adenoma may only require removal of a single gland, while multiple lesions may necessitate total removal with partial tissue transplantation into the forearm muscles to preserve basic PTH secretion. Postoperative calcium and vitamin D supplementation should be adjusted based on blood calcium levels.
Compared to medication, surgery offers a permanent solution, especially for patients with recurrent kidney stones or severe bone density reduction. Modern techniques (such as intraoperative nerve monitoring) also reduce the risk of laryngeal nerve injury, increasing patient acceptance.
Main risks include:
Other potential risks include wound healing issues or inadvertent removal of normal glands leading to compensatory hypofunction. Severe complications such as permanent hypocalcemia may require lifelong calcium supplementation, necessitating strict monitoring. Preoperative assessment and intraoperative PTH monitoring can reduce these risks.
Contraindications include uncontrolled coagulation disorders, severe cardiopulmonary diseases unable to tolerate anesthesia, or patient refusal. Preoperative examinations such as neck ultrasound, sestamibi scan, or blood biochemical tests are necessary to confirm lesion localization.
Postoperative care includes calcium intake management, avoiding high-calcium foods to prevent hypocalcemia symptoms. Patients should avoid strenuous activity for at least 2 weeks and regularly monitor blood calcium and PTH levels. Immediate medical attention is required if swallowing difficulties or persistent hoarseness occur.
Surgery may interact with medications such as bisphosphonates; these should be discontinued preoperatively if they affect bone metabolism. For patients undergoing adrenal or thyroid surgery, combined procedures can reduce the risks associated with repeated anesthesia. Radiation therapy (such as radioactive iodine for thyroid cancer) may affect neck tissues, so informing the surgeon is important for surgical planning.
Compared to drug therapy, surgery does not require long-term medication dependence, but postoperative calcium supplementation may interact with other drugs (such as steroids). Multidisciplinary collaboration is key to successful treatment, with endocrinologists and surgeons jointly planning postoperative management.
Large studies show that for solitary parathyroid adenomas, surgical success rates reach up to 95%, with 90% of patients returning to normal blood calcium levels postoperatively. Long-term follow-up indicates that patients with autotransplantation have a low risk (<10%) of long-term hypocalcemia.
For secondary hyperparathyroidism in chronic kidney disease, surgery effectively reduces blood calcium and improves renal function indicators. Randomized controlled trials confirm that surgery significantly decreases fracture and kidney stone incidence compared to medication, making it the first-line treatment for hypercalcemic crises.
Non-surgical options include:
While medication can temporarily control symptoms, it cannot cure the condition and may cause renal toxicity. Radiation therapy may increase the risk of secondary primary cancers. Therefore, surgery remains the preferred treatment for most cases of hyperparathyroidism.
What preparations are necessary before surgery to ensure a smooth procedure?
Preoperative assessments include blood tests, parathyroid scans, or ultrasound to confirm lesion location. Patients should fast for 12 hours before surgery and stop certain medications (such as anticoagulants) as directed by the physician. Medical staff will explain potential postoperative symptoms and management strategies to ensure patients and their families are fully informed about the surgical process.
How are symptoms of postoperative hypocalcemia identified and managed?
Some patients may experience numbness, cramps, or palpitations due to temporary suppression of parathyroid function. Physicians will prescribe calcium and vitamin D supplements based on blood calcium levels, with regular blood tests to monitor. If symptoms suddenly worsen, immediate medical attention is necessary to adjust medication dosages.
How soon can patients resume daily activities after surgery? What precautions should be taken?
Mild activities such as short walks can usually begin 1-2 days post-surgery, but lifting heavy objects or vigorous exercise should be avoided for at least 2-4 weeks. Return to full-time work varies but generally takes 2-6 weeks. Wound care includes avoiding water contact for 2 weeks and monitoring for bleeding or infection.
What is the long-term success rate of parathyroidectomy?
For primary hyperparathyroidism, minimally invasive surgery has a success rate of about 90-95%, with recurrence rates of approximately 1-5%. Larger resections may be necessary for tumors or multiple gland disease. Long-term follow-up shows that over 85% of patients maintain normal calcium and PTH levels postoperatively, though some may require long-term supplementation.
What dietary adjustments are recommended post-surgery to promote recovery?
Initially, a low-calcium diet is recommended to reduce kidney burden, but long-term intake should be adjusted based on blood calcium levels. Foods rich in magnesium and vitamin D (such as dark green leafy vegetables and fish) are advised, while excessive caffeine or high-phosphorus foods should be avoided to maintain calcium-phosphate balance. Personalized dietary plans are developed by the physician based on individual conditions.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
